[go: up one dir, main page]

BR9808136A - Formulações farmacêuticas contendo substâncias medicamentosas fracamente solúveis. - Google Patents

Formulações farmacêuticas contendo substâncias medicamentosas fracamente solúveis.

Info

Publication number
BR9808136A
BR9808136A BR9808136-5A BR9808136A BR9808136A BR 9808136 A BR9808136 A BR 9808136A BR 9808136 A BR9808136 A BR 9808136A BR 9808136 A BR9808136 A BR 9808136A
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulations
soluble drug
drug substances
formulations containing
poorly soluble
Prior art date
Application number
BR9808136-5A
Other languages
English (en)
Inventor
William L Rocco
Sharon M Laughlin
Nancy M Franson
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/810,560 external-priority patent/US5776987A/en
Priority claimed from US08/813,946 external-priority patent/US5837714A/en
Priority claimed from US08/808,761 external-priority patent/US5760056A/en
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR9808136A publication Critical patent/BR9808136A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"FORMULAçõES FARMACêUTICAS CONTENDO SUBSTâNCIAS MEDICAMENTOSAS FRACAMENTE SOLúVEIS"<D>. São fornecidas formulações farmacêuticas de substâncias de drogas fracamente solúveis sob a forma de soluções concentradas para enchimento de cápsulas de gelatina macia; dispersões sólidas e suspensões para enchimento de cápsulas de gelatina dura. O sistema solvente usado inclui xilitol, diidrato de fosfato dicálcico, monodrato de lactose, celulose microcristalina, propileno glicol e NaOH.
BR9808136-5A 1997-03-03 1998-02-27 Formulações farmacêuticas contendo substâncias medicamentosas fracamente solúveis. BR9808136A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/810,560 US5776987A (en) 1997-03-03 1997-03-03 Pharmaceutical suspension formulation
US08/813,946 US5837714A (en) 1997-03-03 1997-03-03 Solid pharmaceutical dispersions
US08/808,761 US5760056A (en) 1997-03-03 1997-03-03 Pharmaceutical formulation
US2850498A 1998-02-24 1998-02-24
PCT/US1998/004078 WO1998038987A1 (en) 1997-03-03 1998-02-27 Pharmaceutical formulations containing poorly soluble drug substances

Publications (1)

Publication Number Publication Date
BR9808136A true BR9808136A (pt) 2000-03-28

Family

ID=27487679

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808136-5A BR9808136A (pt) 1997-03-03 1998-02-27 Formulações farmacêuticas contendo substâncias medicamentosas fracamente solúveis.

Country Status (10)

Country Link
EP (1) EP0996436B1 (pt)
JP (2) JP4510156B2 (pt)
AT (1) ATE300293T1 (pt)
BR (1) BR9808136A (pt)
CA (1) CA2281946C (pt)
DE (1) DE69830997T2 (pt)
ES (1) ES2242273T3 (pt)
HR (1) HRP980105A2 (pt)
NO (1) NO325726B1 (pt)
WO (1) WO1998038987A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197787B1 (en) * 1997-03-03 2001-03-06 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
AU1881600A (en) * 1998-12-23 2000-07-31 Alza Corporation Dosage forms comprising porous particles
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
MX2010010202A (es) * 2008-03-21 2010-12-21 Smart Salt Inc Sales comestibles tipo carnalita y productos de las mismas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12072T1 (de) * 1981-09-25 1985-03-15 Lacer Sa 1-azaxanthon zur therapeutischen verwendung, verfahren zu seiner herstellung und pharmazeutische zusammensetzungen.
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
WO1993008699A1 (en) * 1991-11-04 1993-05-13 Fuisz Technologies Ltd. Water-soluble delivery systems for hydrophobic liquids
DD293499A5 (de) * 1989-06-06 1991-09-05 Arzneimittelwerk Dresden Gmbh,De Verfahren zur herstellung cyclosporinhaltiger galenischer formulierungen
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
GB9302720D0 (en) * 1993-02-11 1993-03-24 Scherer Ltd R P Products in capsule form for use in aqueous solution

Also Published As

Publication number Publication date
JP5563260B2 (ja) 2014-07-30
CA2281946C (en) 2007-08-07
WO1998038987A1 (en) 1998-09-11
EP0996436B1 (en) 2005-07-27
DE69830997T2 (de) 2006-02-09
EP0996436A4 (en) 2001-04-11
ATE300293T1 (de) 2005-08-15
HRP980105A2 (en) 1999-02-28
JP2009286798A (ja) 2009-12-10
DE69830997D1 (de) 2005-09-01
JP2002513406A (ja) 2002-05-08
NO325726B1 (no) 2008-07-07
JP4510156B2 (ja) 2010-07-21
CA2281946A1 (en) 1998-09-11
NO994249L (no) 1999-11-03
EP0996436A1 (en) 2000-05-03
NO994249D0 (no) 1999-09-02
ES2242273T3 (es) 2005-11-01

Similar Documents

Publication Publication Date Title
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
BRPI9915208B1 (pt) preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.
NO20022998L (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
WO2001034119A3 (en) Inhibitors of crystallization in a solid dispersion
DK4088D0 (da) Blandingsmicelleoploesninger
MA26800A1 (fr) Systemes et methodes aerosoles pour formulations pharmaceutiques.
BR9814818A (pt) Métodos de tratamento de cápsulas e formulações farmacêuticas em pó secas
ATE191468T1 (de) Metalloproteinase inhibitoren
FI962948L (fi) Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
MY124599A (en) Oral suspension of pharmaceutical substance
ATE285754T1 (de) Pharmazeutische zusammensetzung mit lyophilisierten lyposomen welche einen unlöslichen aktiven wirkstoff einschliessen, verfahren zu dessen herstellung
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
NO20024737D0 (no) Farmasöytiske preparater og fremstilling derav
BR9808136A (pt) Formulações farmacêuticas contendo substâncias medicamentosas fracamente solúveis.
ATE247981T1 (de) Proteinenthaltende pharmazeutische zubereitung
DE59708495D1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
PT1178787E (pt) Composicoes farmacologicas para administracao por via oral de floroglucinol e suas preparacoes
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
BR9912125B1 (pt) Benzenossulfoniluréias e - tiouréias 2,5-substituídas, processos para a sua preparação, sua aplicação e preparados farmacêuticos contendo as mesmas
PT742716E (pt) Composicao farmaceutica para administracao transdermica sistemica contendo a substancia activa morfina-6-glucuronido
ATE228842T1 (de) Codein enthaltende formulierungen
BR9708475A (pt) Derivados oxazolidina processos para sua produção e agentes farmacéuticos contendo estes compostos
AR018092A1 (es) Composicion farmaceutica liquida para administracion oral

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AOS REQUISITOS DOS ARTIGOS 8, 13, 24 E 25 DA LPI.